A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

Clinical trial NCT05717166 · RECRUITING

Trial details

NCT number: NCT05717166
Sponsor: David Palma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Tumor

Start date: 2023-10-06
Primary completion: 2029-04-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.